Related Experiment Video

Updated: Jul 6, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Therapeutic vaccine for melanoma: the untouched grail?

ZhenYu Ding1, YuQuan Wei

  • 1Sichuan University, Third Department of Medical Oncology, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, 610041, China. dingzy333@163.com

Expert Review of Vaccines
|April 2, 2008
PubMed

Insights

This study found that a therapeutic vaccine, Melacine, combined with low-dose interferon-alpha(2b), offers comparable efficacy to high-dose interferon-alpha(2b) for advanced melanoma treatment with reduced toxicity.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Malignant melanoma is a lethal cancer, particularly with advanced stages and metastasis.
  • Conventional treatments often fail due to melanoma's resistance.
  • Adjuvant therapies are explored to reduce recurrence and improve response rates.

Discussion:

  • A Phase III trial evaluated Melacine (therapeutic vaccine) plus low-dose interferon-alpha(2b).
  • This combination showed comparable effects to standard high-dose interferon-alpha(2b).
  • The novel approach demonstrated significantly reduced toxicity.

Key Insights:

  • Therapeutic vaccines like Melacine show promise in advanced melanoma treatment.
  • Combining Melacine with low-dose interferon-alpha(2b) is a viable alternative to high-dose interferon.
  • Reduced toxicity enhances patient tolerance and quality of life.

Outlook:

  • Further research into active immunotherapy for melanoma is warranted.
  • This approach could lead to improved treatment protocols for high-risk melanoma patients.
  • Investigating long-term outcomes and broader applicability of this combination therapy is crucial.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccinations01:51

Vaccinations

Overview